AU2002224595A1 - Antitumor agents - Google Patents

Antitumor agents

Info

Publication number
AU2002224595A1
AU2002224595A1 AU2002224595A AU2459502A AU2002224595A1 AU 2002224595 A1 AU2002224595 A1 AU 2002224595A1 AU 2002224595 A AU2002224595 A AU 2002224595A AU 2459502 A AU2459502 A AU 2459502A AU 2002224595 A1 AU2002224595 A1 AU 2002224595A1
Authority
AU
Australia
Prior art keywords
antitumor agents
antitumor
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224595A
Inventor
Tosiyuki Inui
Noriyasu Kuno
Gou Shinohara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Publication of AU2002224595A1 publication Critical patent/AU2002224595A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
AU2002224595A 2000-07-31 2001-07-25 Antitumor agents Abandoned AU2002224595A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000230254 2000-07-31
JP2000-230254 2000-07-31
JP2000-366297 2000-11-30
JP2000366297 2000-11-30
PCT/JP2001/006393 WO2002009719A1 (en) 2000-07-31 2001-07-25 Antitumor agents

Publications (1)

Publication Number Publication Date
AU2002224595A1 true AU2002224595A1 (en) 2002-02-13

Family

ID=26596992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224595A Abandoned AU2002224595A1 (en) 2000-07-31 2001-07-25 Antitumor agents

Country Status (6)

Country Link
US (1) US20030153538A1 (en)
EP (1) EP1321145A4 (en)
CN (1) CN1450900A (en)
AU (1) AU2002224595A1 (en)
CA (1) CA2418117A1 (en)
WO (1) WO2002009719A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
EP1309605A1 (en) * 2000-08-18 2003-05-14 The Board Of Trustees Of The University Of Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
FR2822821B1 (en) * 2001-04-03 2004-05-07 Pharmascience Lab LUPINE SEED HULL EXTRACT CONTAINING LUPEOL, ESPECIALLY EXTRACT RICH IN LUPEOL AND PROCESS FOR PREPARING THE SAME
AU2002367429A1 (en) * 2001-12-28 2003-07-24 The Nisshin Oillio, Ltd. Apoptosis inductor
MXPA04011560A (en) * 2002-05-24 2005-06-08 Greystone Medical Group Inc Anti-cancer formulation.
CN1243538C (en) * 2002-11-21 2006-03-01 武汉利元亨药物技术有限公司 Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method
KR100559489B1 (en) * 2003-08-05 2006-03-10 한국생명공학연구원 Composition comprising ZiZyphy Fructus extract and compounds isolated from above extract for anti-cancer and anti-metastatic
EP1786433A4 (en) * 2004-09-10 2008-02-27 Brij B Saxena Betulinol derivatives as anti-hiv agents
CN109485727A (en) * 2005-05-09 2019-03-19 小野药品工业株式会社 The human monoclonal antibodies of programmed death-1 (PD-1) and the method for carrying out treating cancer using anti-PD-1 antibody
WO2007112043A2 (en) * 2006-03-23 2007-10-04 Advanced Life Sciences Inc. Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
ES2301369B1 (en) * 2006-06-21 2009-06-12 Consejo Superior Investig. Cientificas USE OF EDITRODIOL FOR THE PREPARATION OF A DEATH DRIVING MEDICINAL BY GROWTH IN MALIGN CELLS OF SOLID TUMORS.
ES2328999B1 (en) 2008-04-03 2010-10-27 Biomaslinic S.L. USE OF MASLINIC ACID FOR THE TREATMENT OF PATHOLOGIES AND ITS SYMPTOMS THROUGH THE COH-2 INHIBITION.
CN102008715B (en) * 2009-09-07 2013-02-20 华东师范大学 Antitumor MA-TNF alpha medicine composition and application thereof
JP5548874B2 (en) * 2010-03-31 2014-07-16 富山県 Cancer immunosuppression releasing agent and cancer immunotherapy composition
CN102241723B (en) * 2010-05-11 2015-06-03 上海开拓者医药发展有限公司 Ursolate as well as preparation method and crystal thereof
CN103037692B (en) * 2010-05-20 2015-02-25 爱荷华大学研究基金会 Methods for inhibiting muscle atrophy
WO2012170546A1 (en) 2011-06-06 2012-12-13 University Of Iowa Research Foundation Methods of inhibiting muscle atrophy
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CN102106858A (en) * 2010-09-27 2011-06-29 林秀坤 Anti-cervical carcinoma effect of maslinic acid and medicinal preparation thereof
CN102106859A (en) * 2010-09-27 2011-06-29 林秀坤 Breast cancer-resisting function and pharmaceutical preparation of maslinic acid
CN102225068A (en) * 2010-09-27 2011-10-26 林秀坤 Anti-ovarian cancer effect of maslinic acid and medicinal preparation thereof
CN102091078A (en) * 2010-09-27 2011-06-15 林秀坤 Maslinic acid anti-hepatocarcinoma effect and maslinic acid medicinal preparation
CN102106861A (en) * 2010-09-27 2011-06-29 林秀坤 Anti-colon cancer effect of maslinic acid and medicinal preparation thereof
CN102151276A (en) * 2010-11-07 2011-08-17 林秀坤 Pancreatic cancer resistance effect and pharmaceutical preparation of crataegolic acid
JP2013010715A (en) * 2011-06-29 2013-01-17 Nippon Flour Mills Co Ltd Dental caries preventive agent, periodontal disease preventive agent, and composition for oral cavity
RU2475025C1 (en) * 2011-07-27 2013-02-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Agent for treating seeds of grain and leguminous crops infected with fusarium blight
CN103202898B (en) * 2013-03-29 2014-04-16 阚兆云 Traditional chinese medicine composition and preparation method thereof
KR20200052925A (en) * 2017-09-13 2020-05-15 엠욘 인코퍼레이티드 Ursolic acid morpholine and diethanolamine salts
CN108686220A (en) * 2018-07-13 2018-10-23 刘慧荣 A kind of antitumor agent for thyroid cancer
CN112353827B (en) * 2020-12-07 2022-05-27 山东省分析测试中心 Application of VSM in preparation of medicines for treating rhabdomyosarcoma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400186A (en) * 1889-03-26 Portable wash-stand
JPS6357519A (en) * 1986-08-28 1988-03-12 Minofuaagen Seiyaku Honpo:Goushi Agent for suppressing carcinogenic promotor
JPH064563B2 (en) * 1986-08-29 1994-01-19 理化学研究所 Triterpene compound and anticancer agent
JPH01143832A (en) * 1987-12-01 1989-06-06 Toa Nenryo Kogyo Kk Carcinostatic agent
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
DE29508355U1 (en) * 1995-05-24 1996-09-26 Linck Masch Gatterlinck Device for cutting logs into wood products and milling head for such a device
JP3984310B2 (en) * 1995-06-22 2007-10-03 日本製粉株式会社 Glycerophosphate dehydrogenase inhibitor
JP3041232B2 (en) * 1995-11-16 2000-05-15 日本ケミカルリサーチ株式会社 Cancer metastasis inhibitor
US5916919A (en) * 1997-06-27 1999-06-29 Dalhousie University Retrovirus protease inhibitors

Also Published As

Publication number Publication date
EP1321145A4 (en) 2006-03-22
WO2002009719A1 (en) 2002-02-07
EP1321145A1 (en) 2003-06-25
CA2418117A1 (en) 2003-01-30
US20030153538A1 (en) 2003-08-14
CN1450900A (en) 2003-10-22

Similar Documents

Publication Publication Date Title
AU2002224595A1 (en) Antitumor agents
AU2002221344A1 (en) Antiviral agents
AU2001262847A1 (en) Language-understanding
AU2001228708A1 (en) Coin-validation arrangement
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU7446000A (en) Antitumor agents
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2001262711A1 (en) Cytoprotectors
AU2001284173A1 (en) Calycins
AU2001260192A1 (en) Glycinamides
AU2001226668A1 (en) Crankshaft-starter-generator